Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 176 participants.

Also called NCT01011699

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 176 participants (enrolled count) (from the registry)
Sponsor
Centre Hospitalier Universitaire, Amiens (from the registry)
Registry
  • NCT NCT01011699
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01011699. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2013-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Acronym
NICOREN
Condition
Chronic Renal Failure
Condition
Hemodialysis
Intervention (Drug)
nicotinamide
Intervention (Drug)
sevelamer
Intervention (Drug)
cinacalcet
Lead sponsor
Centre Hospitalier Universitaire, Amiens (class: other)

Record details

Record id
cardio:ct-nct01011699
Content hash
97b42bf7c1dbc93a4a0ea67594000f099ea4b4370f35456a286d9f9c8308b72d